Cue Biopharma CUE
€ 1.04
5.93%
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Cue Biopharma Gewinn / Verlust 2011-2024 | CUE
Gewinn / Verlust Jährlich Cue Biopharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
86.5 M | 108 M | 354 M | 388 M | 337 M | 101 M | 311 M | - | - | - | - | - | - |
Anteile |
45.8 M | 35.6 M | 31.3 M | 28.7 M | 22 M | 20.1 M | 20.6 M | - | - | - | - | - | - |
Kurshistorie |
1.89 | 3.04 | 11.3 | 12.5 | 15.9 | 4.7 | - | - | - | - | - | - | - |
Nettogewinn |
-50.7 M | -53 M | -44.2 M | -44.8 M | -36.7 M | -39 M | -23.2 M | -7.66 M | -1.93 M | - | - | - | - |
Umsatz |
5.49 M | 1.24 M | 14.9 M | 3.15 M | 3.46 M | 1.14 M | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | 3.15 M | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-52.1 M | -53.2 M | -43.7 M | -45 M | -36.8 M | -38.7 M | -23.2 M | - | - | - | - | - | - |
Zinsaufwendungen |
130 K | 109 K | - | - | 64.1 K | 165 K | - | - | - | - | - | - | - |
EBITDA |
-51.6 M | -52.3 M | -42.5 M | -44 M | -31.6 M | -37.9 M | -22.8 M | -7.46 M | -1.88 M | - | - | - | - |
Betriebsaufwand |
57.6 M | 54.5 M | 58.7 M | 48.2 M | 40.2 M | 39.8 M | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
16.7 M | 16.2 M | 17.3 M | 14.7 M | 12.7 M | 11.3 M | 4.33 M | 1.97 M | 425 K | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Cue Biopharma
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
51.2 M | 50.2 M | 47.2 M | 46.4 M | 44.8 M | 44.7 M | 43 M | 35.4 M | 35.4 M | 32.6 M | 32.2 M | 31.3 M | 31.2 M | 30.4 M | 30.4 M | 29.7 M | 28.2 M | 26.6 M | 26.6 M | 22.5 M | 20.8 M | 20.7 M | 20.7 M | 20.1 M | 20.1 M | 20.1 M | 19.5 M | 10.6 M | 10.6 M | 10.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-8.66 M | -10.2 M | - | -11 M | -13.2 M | -13.1 M | - | -11 M | -13.2 M | -14.3 M | - | -13 M | -10.3 M | -12.5 M | - | -10 M | -10.8 M | -12.8 M | - | -6.99 M | -9.52 M | -11.3 M | - | -12.6 M | -7.3 M | -7.52 M | - | -5.03 M | -4.41 M | -3.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
3.34 M | 2.66 M | - | 2.1 M | 1.38 M | 187 K | - | 68 K | 26 K | 1 M | - | 2.4 M | 2.74 M | 1.55 M | - | 704 K | 1.08 M | 900 K | - | 984 K | 1.06 M | 370 K | - | 449 K | 172 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-8.82 M | -10.4 M | - | -11.4 M | -13.5 M | -13.4 M | - | -11 M | -13.1 M | -14.2 M | - | -13 M | -10.3 M | -12.5 M | - | -10.1 M | -10.9 M | -13 M | - | -7.09 M | -9.23 M | -11.4 M | - | -12.8 M | -7.47 M | -7.52 M | - | -5.03 M | -4.41 M | -3.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
-188 K | -215 K | - | -286 K | -232 K | 330 K | - | 33 K | 33 K | -25 K | - | - | - | - | - | -23 K | -25 K | -26 K | - | 5 K | 26 K | 46 K | - | 98 K | 2 K | -1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-8.72 M | -10.3 M | - | -11.3 M | -13.4 M | -13.2 M | - | -10.8 M | -12.9 M | -13.9 M | - | -12.1 M | -10.1 M | -12.2 M | - | -9.33 M | -10.4 M | -12.7 M | - | -6.49 M | -8.82 M | -11.2 M | - | -12.6 M | -7.28 M | -7.36 M | - | -4.74 M | -4.24 M | -3.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
12.2 M | 13 M | - | 13.5 M | 14.9 M | 13.6 M | - | 11.1 M | 13.1 M | 15.2 M | - | 15.4 M | 13 M | 14.1 M | - | 10.8 M | 12 M | 13.9 M | - | 8.08 M | 10.3 M | 11.8 M | - | 13.2 M | 7.64 M | 7.52 M | - | 5.03 M | 4.41 M | 3.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
2.87 M | 3.51 M | - | 3.64 M | 4.25 M | 4.18 M | - | 3.53 M | 3.78 M | 5.16 M | - | 4.12 M | 4.28 M | 4.26 M | - | 3.32 M | 3.9 M | 3.99 M | - | 2.78 M | 3.42 M | 3.44 M | - | 2.9 M | 2.23 M | 1.7 M | - | 1.03 M | 996 K | 889 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung